WASHINGTON, D.C. – This week, U.S. Representative Mike Kelly (R-PA), co-chair of the Congressional Childhood Cancer Caucus, joined Representatives Michael McCaul (R-Texas) and Ami Bera, M.D. (D-Calif.) in introducing the Accelerating Innovation (AI) for Kids Act, bipartisan legislation that would accelerate the use of artificial intelligence (AI) to improve and transform pediatric cancer research, treatment options, and data storage.
The legislation builds on efforts to harness emerging technologies to advance pediatric cancer research, improve patient care, and expand treatment opportunities for children battling cancer.
“Congress should always consider new, innovative ways not only to treat cancer, but to defeat cancer,” said Rep. Kelly. “This legislation would leverage artificial intelligence to strengthen patient care and patient outcomes. I’m proud to sponsor the bipartisan Accelerating Innovation (AI) for Kids Act as we work to ensure pediatric cancer patients and their families have every tool at their disposal to receive the care and cures they deserve.”
“Since I founded the Childhood Cancer Caucus 17 years ago, advancements in technology have radically expanded the frontiers of healthcare,” said Rep. McCaul. “We owe it to our nation’s children to leverage cutting-edge AI to improve their care and treatment options. I’m proud to introduce this bill, which codifies and builds on President Trump’s executive order to unlock cures for pediatric cancer patients. By empowering AI to continuously drive research forward, we move one step closer to beating this heartbreaking disease once and for all.”
“Pediatric cancer remains one of the most heartbreaking diagnoses any family can face, and we have a responsibility to use every tool available to improve outcomes for children,” said Rep. Bera. “The bipartisan Accelerating Innovation in Medicine for Kids with Cancer Act would leverage cutting-edge AI and data tools to transform pediatric cancer research, improve clinical trial design and access, and deliver more personalized treatment options for young patients. I am proud to support this effort to accelerate innovation, strengthen the Childhood Cancer Data Initiative, and move us closer to ending cancer as we know it.”
The Accelerating Innovation (AI) for Kids Act would leverage artificial intelligence to strengthen pediatric cancer research, improve clinical trial design and access, enhance data storage and sharing, and support more personalized treatment options for children with cancer.
Click herefor the full text of the Accelerating Innovation (AI) for Kids Act.
Hours: 9:00AM-5:00PM
Hours: 9:00AM-5:00PM
Hours: 9:00AM-5:00PM